Helios 5.8 mg

Helios 5.8 mg by Dragon Pharma – Dual-Action Injectable Fat Burner

Helios 5.8 mg by Dragon Pharma is a potent injectable blend combining Clenbuterol (80 mcg) and Yohimbine (5 mg) per mL. Designed for targeted fat loss and enhanced thermogenesis, this compound is a top choice for competitive bodybuilders and advanced users aiming to shred stubborn fat zones, especially around the abdomen and lower back.

Lab Test Report

How Helios Works

Clenbuterol acts as a beta-2 agonist that increases core body temperature and stimulates the central nervous system to promote fat mobilization. Yohimbine complements it by blocking alpha-2 adrenergic receptors, further enhancing lipolysis in stubborn fat areas. According to research on adrenergic receptor modulation, this synergy makes Helios ideal for fast-paced cutting phases.

Injection Protocol and Dosing

Helios is often injected subcutaneously into localized fat deposits. Most users begin with 0.5–1 mL per day, split into two administrations (morning and afternoon). Because of Yohimbine's potency, it's advised to start with low doses and increase gradually. Avoid taking with food, especially carbs, as it blunts Yohimbine's effect.

Effective Cutting Stacks

Many athletes integrate Helios into short pre-contest stacks or 4–6 week fat-loss cycles. It's commonly combined with oral fat burners or thyroid analogs like T3 or T4, and sometimes paired with Winstrol for simultaneous cutting and hardening. For more aggressive stacks, see this injectable thermogenic protocol.

Helios 5.8 mg Benefits

• Targets stubborn fat areas more aggressively than oral clen
• Boosts thermogenesis and energy levels
• Improves vascularity and muscle definition
• Fast-acting and easy to integrate into cutting cycles

Post-Cycle Considerations

Helios does not suppress testosterone but can stress the CNS. A break of at least 2–4 weeks is recommended after a cycle. If stacked with anabolic compounds, plan post-cycle therapy using Clomid or Nolvadex as needed.

FAQ: Helios 5.8 mg by Dragon Pharma